Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin

被引:7
|
作者
Keck, Megan [1 ,2 ]
Mindru, Cezarina [1 ]
Kalil, Andre C. [1 ]
Mercer, David F. [3 ]
Florescu, Diana F. [1 ]
机构
[1] Univ Nebraska, Med Ctr, Div Infect Dis, Omaha, NE 68198 USA
[2] Nebraska Med Ctr, Dept Pharmaceut & Nutr Care, Omaha, NE USA
[3] Univ Nebraska, Med Ctr, Transplant Surg Div, Omaha, NE 68198 USA
关键词
respiratory syncytial virus; pediatric liver transplantation; treatment; STEM-CELL TRANSPLANTATION; VIRAL-INFECTIONS; IMMUNOCOMPROMISED PATIENTS; SINGLE-CENTER; THERAPY; FEATURES; DISEASES; CHILDREN;
D O I
10.1111/j.1399-3046.2012.01700.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The mainstay of therapy for RSV disease is supportive care, although aerosolized ribavirin has been used to treat infants and young children with severe lower respiratory tract infections. Aerosolized ribavirin has adverse effects, high cost and teratogenic potential. We report the case of a pediatric liver transplant recipient diagnosed with lower respiratory RSV infection, who was successfully treated with oral ribavirin.
引用
收藏
页码:E348 / E351
页数:4
相关论文
共 50 条